Ancora Advisors’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-519
Closed -$154K 2074
2022
Q4
$154K Hold
519
﹤0.01% 727
2022
Q3
$151K Hold
519
﹤0.01% 804
2022
Q2
$151K Hold
519
﹤0.01% 840
2022
Q1
$152K Hold
519
﹤0.01% 887
2021
Q4
$150K Hold
519
﹤0.01% 900
2021
Q3
$151K Buy
+519
New +$151K ﹤0.01% 864

Other funds holding XAGE

Ancora Advisors's XAGE Position: Q1 2023 in Review

Ancora Advisors sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q1 2023, closing a stake of 519 shares — an estimated $154K sold.

Ancora Advisors first reported a position in XAGE in Q3 2021 and held it in 6 quarters. The position peaked at $154K in Q4 2022. 40 funds tracked by Wall St. Rank hold XAGE as of Q1 2023.

  • Ancora Advisors reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ancora Advisors sold 519 Longevity Health Holdings, Inc. Common Stock shares in Q1 2023, an estimated $154K.
  • Ancora Advisors first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Ancora Advisors's Longevity Health Holdings, Inc. Common Stock position peaked at $154K in Q4 2022.
  • 40 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q1 2023.

Based on Ancora Advisors's 13F filing for Q1 2023, filed 16 May 2023.